BioPharma
Bavarian Nordic Agrees for a $3 Bn Take-Private Offer
Bavarian Nordic, the vaccine maker, on July 28 said that it has agreed in principle for roughly $3 bn take-private offer from private equity firms...
BioPharma
South Korea – A Biopharma Innovation Hub With 113%...
The biopharmaceutical sector of South Korea has seen a growth in innovators and drug licensing agreements by way of reaching a total deal value of...
BioPharma
Vinay Prasad Leaves the FDA – An Abrupt End...
The head of the Food and Drug Administration office, overseeing vaccines and gene therapy, Vinay Prasad leaves the FDA after taking over his job just...
Drug Research
Resistance-Evasive Antibiotic for Genes-Free Clinics
In a startling figure, multidrug-resistant bacteria kill almost 5 million people every year, with newly resistant germs emerging faster than the scientists can actually develop the...
News
Why Custom Tin Containers Are Reshaping Medicine & Supplement...
In an industry driven by both compliance and consumer confidence, pharmaceutical and nutraceutical brands are increasingly turning toward robust and reusable packaging alternatives. One solution...
Clinical Trials
Sarclisa by Sanofi has EC Approval to Treat Multiple...
In order to treat multiple myeloma in adults, Sarclisa from Sanofi in combination with a regimen of lenalidomide, bortezomib, and dexamethasone (VRd) has been granted...
News
US Levies 15% Tariff on EU for Pharmaceutical Products
The European Union is going to pay the US a tariff rate of 15% when it comes to pharmaceutical products as part of a new...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.